
OSF Ventures
Description
OSF Ventures is the corporate venture capital arm of OSF HealthCare, a leading integrated health system based in Peoria, Illinois. Established with a strategic imperative, the firm focuses on investing in innovative healthcare technology, digital health, medical devices, and diagnostics that align with OSF HealthCare's mission to transform patient care and improve operational efficiencies. Their investment strategy is deeply rooted in identifying solutions that can be integrated into clinical practice, offering a unique value proposition to portfolio companies beyond just capital.
The firm primarily targets early to growth-stage companies, often participating in Series A and B rounds. OSF Ventures seeks out technologies and solutions that address critical challenges within the healthcare ecosystem, including enhancing patient experience, improving clinical outcomes, reducing costs, and expanding access to care. Their strategic alignment allows them to provide portfolio companies with invaluable access to OSF HealthCare's extensive clinical expertise, real-world testing environments, and potential for rapid adoption within a large health system.
OSF Ventures has demonstrated a strong commitment to fostering innovation, evidenced by the successful closing of its third fund, OSF Ventures III, at $100 million in 2021. This substantial fund enables them to continue their impactful investments in the evolving healthcare landscape. Typically, their initial investment check sizes range from $500,000 to $5 million, though they often participate in larger syndicated rounds. This approach underscores their role as a strategic partner, not just a financial one, aiming to accelerate the development and adoption of groundbreaking healthcare solutions.
Investor Profile
OSF Ventures has backed more than 31 startups, with 3 new investments in the last 12 months alone. The firm has led 6 rounds, about 19% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Medical, Medical Device.
- Typical check size: $500K – $5M.
Stage Focus
- Series B (29%)
- Series A (23%)
- Series C (16%)
- Series Unknown (16%)
- Series D (6%)
- Seed (3%)
- Corporate Round (3%)
- Series E (3%)
Country Focus
- United States (97%)
- Israel (3%)
Industry Focus
- Health Care
- Medical
- Medical Device
- Health Diagnostics
- Machine Learning
- Artificial Intelligence (Ai)
- Hospital
- Information Technology
- Biotechnology
- Mental Health
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.